Global Pharmaceutical War Games Companies: Strengthening Competitive Strategy through Simulation
Pharma companies work in a landscape where clinical developments, regulatory decisions, product launches, pricing decisions, market access decisions and competition can change all the time and quickly. Under these circumstances, traditional planning might not have accounted for the possible reactions of competitors and other stakeholders. Pharmaceutical war games companies tackle this challenge by developing similar simulated scenarios where teams practice possible market changes and strategies that can be employed.
In a pharmaceutical war game, participants are usually assigned the role of a competitor, a payer, a prescriber, a regulator, a patient or another key player. Teams then react to changing scenarios, which enables organizations to test assumptions, uncover vulnerabilities, and consider other courses of action. Specialist providers can group their skills and experience across competitive intelligence, scenario development, facilitation, and strategic analysis to develop simulations around specific therapeutic areas or business challenges.
Pharmaceutical Showdown Unleashing Growth Factors for Victory
As the competition in the pharmaceutical industry grows more complex, so does the growth of war gaming services. Drug development and commercialization represent a number of stakeholders, and every decision they make can shape the course of a product. A competitor could adopt a different clinical strategy, move position, speed a launch, move to a new indication, or adopt a new commercial approach. Leadership teams can consider the impact of such moves within the context of current plans through war games.
Pharma companies gather a lot of data regarding competitors, clinical pipelines, market access, regulatory updates, and treatment landscapes. Analyzing that information and deriving strategic value from it requires teams to think about what they might be able to do next, in addition to what their competitors have done. Prior to competing in a market, firms can emulate the reaction of existing drugs, new products, healthcare providers, healthcare payers, and other market players. Competition in markets for rare diseases, biologics, advanced therapies, and highly differentiated treatment approaches can be unique.
War games can be used as a tool to explore these dynamics in a more specific way than through traditional market assessments, as this involves a team of players. Manufacturers of pharmaceuticals might want to take steps to account for manufacturing disruptions, regulatory adjustments, market access advances or changing conditions in the international operating environment. Leadership teams can use scenario planning to discuss the interconnections of risks and plan for coordinated action.
Tech-Driven Strategies Revolutionizing Warfare
New digital platforms and sophisticated analytics can now enable more dynamic environments, allowing participants to consider a variety of factors and varying conditions. AI is now starting to shape the war game environment by sifting through vast amounts of competitive data, pinpointing trends, creating scenarios, and simulating likely responses from all stakeholders. AI-powered techniques can add more potential scenarios to a simulation, but relying on human judgment is crucial when deciding on the strategic implications of a scenario.
The commercial team can join the exercise along with medical, regulatory, market-access, clinical development, finance, supply-chain, and corporate strategy specialists. When several points of view are put together in the same environment, some dependencies may be discovered by them that single functions may not. Exercises should not only consider direct competitors but can also include payer behavior, physician preferences, patient expectations, regulatory decisions, treatment guidelines and other market influences.
International teams can be physically dispersed, and this allows organizations to engage regional and global stakeholders in the same strategic exercise. Digital formats can allow for easier repetition of simulations when the market changes. The technology should be used to serve the purpose of the exercise, and should not be the purpose of the exercise. The good providers start with a set of questions and develop the game around decisions that need to be made by the leadership team.
Battlegrounds of Innovation in Pharma's Global Arena
War gaming in the future will come increasingly from a continuous strategic preparedness, and less from a series of workshops. Simulations can be employed during the product lifecycle at various junctures, including when there are major competitive, clinical, regulatory or commercial events. Pre-launch simulations will continue to be useful as they enable organizations to run a series of tests on positioning, market-access assumptions, stakeholder reactions, and competitor reactions prior to commercial execution.
In the future, companies will look increasingly for war games to include real-time competitive developments, shifting clinical evidence, access to the market and changing stakeholder behavior. The capacity to turn simulation results into real-world strategic decisions will also be a big factor. A positive war game should result in clearer assumptions, vulnerabilities identified, alternative responses, and areas to further investigate. The usefulness lies in the linkage of simulation to real-life planning and decision-making.
Global pharmaceutical war games companies will be playing a more strategic role in a more interconnected and less predictable pharmaceutical competition. They develop competitive scenarios and assist organizations in practicing uncertainty, questioning internal assumptions, ensuring cross-functional alignment, and preparing for decisions that can have far-reaching implications throughout the product lifecycle.
